Sartorius | SRT3 - Sales Revenues

Stock Price
233.60
Daily Change
-2.20 -0.93%
Monthly
-8.21%
Yearly
-14.15%
Q1 Forecast
228.84

Sartorius reported EUR843.2M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.1B 80M Sep/2025
Moderna USD 1.02B 878M Sep/2025
Organon & Co USD 1.6B 10M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Sartorius EUR 843.2M 41.1M Sep/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025